<unk>  is a Proteasome Inhibitor that is FDA approved for the treatment of Multiple Myeloma, Mantle Cell Lymphoma.   Common adverse reactions include hypotension, rash, constipation, decrease in appetite, diarrhea, nausea, vomiting, anemia, arthralgia, bone pain, cramp, myalgia, asthenia, dizziness, dysesthesia, headache, insomnia, paresthesia , peripheral neuropathy, mental disorder, cough, dyspnea, lower respiratory tract infection, fever.
Bortezomib
Lenalidomide
Ixazomib
Pomalidomide
Ifosfamide
Rituximab
Carfilzomib
Bosutinib